A strengthened partnership with ISPE to drive innovation and best practices in the pharmaceutical sector
We are proud to announce the renewal of the partnership between MAASI Enterprises and the International Society for Pharmaceutical Engineering (ISPE), with an upgrade from Silver to Gold Corporate Partner status for 2024/25. This marks the third consecutive year of collaboration between the two organisations, underscoring MAASI’s commitment to advancing technology and best practices in the pharmaceutical industry.
ISPE is a global, non-profit organisation that brings together leading experts and professionals in the pharmaceutical field, fostering collaboration, knowledge-sharing, and industry advancement across the entire drug lifecycle. Becoming a Gold Corporate Partner grants us access to exclusive resources, advanced insights, and best practices, enhancing our ability to deliver high-value, innovative solutions to our clients.
Our membership with ISPE is a strategic move for MAASI to strengthen our role as a consulting and advisory partner within the Life Sciences sector, where standards of excellence, sustainable innovation, and regulatory compliance are paramount. By working with ISPE and its members, we are dedicated to contributing to the ongoing development of the sector, aiming to improve the quality and reliability of manufacturing processes and the supply chain.
“Our evolution from Silver to Gold partnership with ISPE reflects MAASI’s commitment to supporting the growth of the pharmaceutical sector, providing ever more advanced, future-oriented solutions,” stated Leonardo Zanus, Managing Director of MAASI Enterprises. “We are excited to continue this journey and to promote excellence and innovation in the industry together.”
For further information on ISPE and its initiatives, please visit their official website: ispe.org